Rivaroxaban
Brand name: Xarelto
Rank #5 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$2.45B
Total Cost
2,628,123
Total Claims
$2.45B
Total Cost
59,146
Prescribers
$934
Cost per Claim
397,398
Beneficiaries
4,585,380
30-Day Fills
$41K
Avg Cost/Provider
44
Avg Claims/Provider
Share of Medicare Part D Spending
0.89%
of total Medicare Part D spending
$2.45B of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $2.45B total
🔎 Data Overview
Rivaroxaban is the #5 most expensive drug in Medicare Part D, costing taxpayers $2.45B in 2023. The top 10 drugs alone account for roughly 20% of all Part D spending.
Average cost of $6,175 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Rivaroxaban
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Mayer Rashtian | Clinical Cardiac Electrophysiology | Pasadena, CA | 2,013 | $2.4M |
| 2 | Prakash Shah | Cardiology | Milwaukee, WI | 1,831 | $2.2M |
| 3 | Jennifer Tresser | Pharmacist | Martinez, CA | 1,412 | $1.8M |
| 4 | Mauricio Melhado | Cardiology | West Palm Beach, FL | 1,842 | $1.5M |
| 5 | Yili Huang | Cardiology | Elmhurst, NY | 1,284 | $1.5M |
| 6 | Jordan Wong | Pharmacist | San Francisco, CA | 1,211 | $1.5M |
| 7 | Ajay Tuli | Interventional Cardiology | Tucson, AZ | 1,002 | $1.3M |
| 8 | Carmen Wong | Pharmacist | Union City, CA | 1,033 | $1.2M |
| 9 | Tiffany Bennett | Nurse Practitioner | Corinth, MS | 713 | $1.2M |
| 10 | Cres Miranda | Cardiology | Las Vegas, NV | 910 | $1.2M |
| 11 | Hossein Amirani | Cardiology | Wichita, KS | 1,303 | $1.2M |
| 12 | Ronald Ryder | Cardiology | Hamilton, NJ | 950 | $1.1M |
| 13 | Hakim Morsli | Cardiology | Sarasota, FL | 801 | $1.1M |
| 14 | James Chambers | Cardiology | Flint, MI | 841 | $1.0M |
| 15 | Gary Reznik | Cardiology | Los Angeles, CA | 1,621 | $1.0M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 2 | Semaglutide (Ozempic) | $4.30B | 3,193,643 |
| 3 | Empagliflozin (Jardiance) | $3.58B | 3,334,784 |
| 4 | Dulaglutide (Trulicity) | $2.99B | 2,175,100 |
| 5 | Rivaroxaban (Xarelto) | $2.45B | 2,628,123 |
| 6 | Adalimumab (Humira(Cf) Pen) | $2.17B | 240,925 |
| 7 | Lenalidomide (Revlimid) | $2.15B | 130,834 |
| 8 | Insulin Glargine,hum.Rec.Anlog (Lantus Solostar) | $1.94B | 3,118,259 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology